Showing results (481-490 of 583) with videos related to
Sort By:
Pageof 59
Antimicrobial Agents and Chemotherapy|January 24, 2008
Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agentRoger G Ptak, Philippe A Gallay, Dirk Jochmans, et al.European Journal of Medicinal Chemistry|December 9, 2014
New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2Dinesh Manvar, Sveva Pelliccia, Giuseppe La Regina, et al.Journal of Medicinal Chemistry|September 30, 2022
Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main ProteaseMark S Cooper, Linlin Zhang, Mohamed Ibrahim, et al.ACS Medicinal Chemistry Letters|May 16, 2022
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus ActivityMaria Giulia Nizi, Leentje Persoons, Angela Corona, et al.Hepatology (Baltimore, Md.)|October 20, 2012
The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral disseminationMuhammad N Zahid, Marine Turek, Fei Xiao, et al.Journal of Virology|August 10, 2007
The imidazopyrrolopyridine analogue AG110 is a novel, highly selective inhibitor of pestiviruses that targets the viral RNA-dependent RNA polymerase at a hot spot for inhibition of viral replicationJan Paeshuyse, Jean-Michel Chezal, Matheus Froeyen, et al.Antimicrobial Agents and Chemotherapy|March 9, 2011
Preclinical characterization of naturally occurring polyketide cyclophilin inhibitors from the sanglifehrin familyMatthew A Gregory, Michael Bobardt, Susan Obeid, et al.ACS Infectious Diseases|February 7, 2018
Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-onesAsier Gómez-SanJuan, Ana-María Gamo, Leen Delang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 22, 2022
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunitySean McCafferty, A K M Ashiqul Haque, Aster Vandierendonck, et al.Antimicrobial Agents and Chemotherapy|April 20, 2021
Structural Insights into the Mechanisms of Action of Functionally Distinct Classes of Chikungunya Virus Nonstructural Protein 1 InhibitorsKristina Kovacikova, Marina Gorostiola González, Rhian Jones, et al.Pageof 59